ロード中...
One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
BACKGROUND: Central serous chorioretinopathy (CSC) is characterized by an accumulation of subretinal fluid (SRF) in the macula. It is usually treated by laser photocoagulation or photodynamic therapy (PDT) with consisting of different doses and power. This study aimed to compare the efficacy of half...
保存先:
| 出版年: | BMC Ophthalmol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7802284/ https://ncbi.nlm.nih.gov/pubmed/33430812 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12886-020-01796-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|